Alana Hippensteele, Lead Editor

A virtual event was hosted on July 28 by the Economic Club of Washington, DC, on how to immunize Americans as fast as possible upon the release of a COVID-19 vaccine.

The FDA released a recent statement explaining that it is now recommending all pharmacists discuss naloxone with patients when prescribing opioid pain relievers or medicines to treat opioid use disorder (OUD).

Habits are not set in stone, as there are biological pathways that researchers have explored that highlight how mindset can be beneficial in changing preexisting habits.

The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.

The International Society for Pharmaceutical Engineering (ISPE) released its newest guide to help pharmaceutical organizations achieve and maintain control in their critical utility systems.

At the National Pharmacy Technician Association’s virtual Pharmacy Technician Student Summit, Jamie McGuire, the pharmacy technician program director, discussed the role of professionalism in the lives of pharmacy technician students.

At the 2020 Virtual Conference on Pediatric Health Care, Kimberly Erlich presented an update on current understandings of pharmacogenomic testing and its use as a tool in the treatment of behavioral health issues in a pediatric population.

The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.

According to a recent analysis published in the Annals of the American Thoracic Society, Black individuals are twice as likely as White individuals to test positive for COVID-19.

According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.

Pharmacy Times® interviewed Tim Safley, program director of the Accreditation Commission for Health Care (ACHC), and Jon Pritchett, program director of ACHC, on the value of specialty pharmacy and LTC accreditation for pharmacies.

According to an online survey of more than 53,000 Americans using PPIs, once or twice daily use significantly increases the likelihood of a positive test for COVID-19.

Probiotic therapy either with prebiotics or by itself may ease depression, according to a review of the data recently published in BMJ Nutrition Prevention & Health.

The diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) in children and teens can be a complex and unique challenge for providers.

At the 2020 Virtual Conference on Pediatric Health Care, Dawn Garzon Maaks, discussed important elements in the diagnosis and treatment of tics in children with ADHD.

Although many children have normal fears for their age that are not a sign of anxiety, fears become anxiety when they are impairing a child's life.

Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.

According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.

A recent study showed that long-term exposure to fine particulate outdoor air pollution is a key contributor to cardiovascular disease and death throughout the world, regardless of the income bracket of the various countries.

A recent qualitative study presented a potential explanation for why health system specialty pharmacies often find it difficult to partner with payers.

New contraceptive from Evofem Biosciences maintains acidic environment inhospitable to sperm.

A study presented at the Society of Gynecologic Oncology 2020 Annual Meeting on Women’s Cancer showed menstrual cups may provide a novel, less invasive, and more comfortable approach to the diagnosis of endometrial cancer.

A phase 2 clinical trial demonstrated that a 2-week course of teplizumab was able to delay the onset of clinical type 1 diabetes by 3 years compared with patients taking a placebo.

According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.

Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.

According to a recent study presented at the ADA’s 80th Scientific Sessions, youth and young adults with type 1 diabetes (T1D) in the United States today have worse glycemic control than prior generations.

Treatment of recently diagnosed patients with type 1 diabetes (T1D) with anti-IL-21 and liraglutide for 54 weeks was found to be safe and resulted in sustained insulin secretion and lower insulin dose.

The results of the study demonstrated that dapagliflozin was able to reduce new-onset diabetes by 32%.

FDA officials based their approval on the review of data and evidence that demonstrated a close similarity between pegfilgrastim-apgf and its reference product.

According to a recent study, patients with type 2 diabetes mellitus (T2D), but not prediabetes, demonstrated poorer cognitive performance 3 to 6 months after a stroke.